Patient-Friendly Explanation
This hypothesis says each person’s fat tissue can only expand so far before it stops storing energy safely. Once that limit is reached, fat spills into the liver, muscle and pancreas, where it causes insulin resistance and inflammation. It helps explain why some people with obesity stay metabolically healthy while others develop diabetes at a much lower weight.
Clinical Definition
The adipose tissue expandability hypothesis proposes that metabolic complications arise from failure of subcutaneous adipose tissue to accommodate further lipid storage rather than from total fat mass itself. Once subcutaneous capacity is exceeded, lipid is deposited ectopically in liver, skeletal muscle, myocardium and pancreatic islets, producing lipotoxicity, insulin resistance and beta-cell dysfunction. Determinants of storage capacity include adipocyte number and size, subcutaneous depot anatomy, and genetic variation in adipogenic pathways.
Why It Matters
This model explains the metabolic heterogeneity behind obesity phenotypes and why waist-to-height ratio and liver fat predict risk better than BMI alone. Clinically it supports preferentially reducing visceral and ectopic fat with GLP-1 based therapy instead of chasing scale weight.